We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The ...

A 72-year-old man from Youngstown, Ohio, has now completed a more than 2,200 mile fundraising bike ride across the country to ...

Are veterans more prone to Alzheimer’s disease? According to the U.S. Department of Veterans Affairs, veterans are more ...

Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

Health conditions associated with Alzheimer’s can arise well before the diagnosis of this devastating disease.

Dr Charles Vega believes that primary care will be the chief clinical setting for application of new blood-based biomarkers.

That disease is Alzheimer’s disease. Let’s begin with some definitions. Alzheimer’s disease is a degenerative brain disease ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Scientists have discovered that the enzyme TYK2 modifies tau proteins, leading to their accumulation in the brain—a key ...

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...

MANSFIELD –Residents from Richland and surrounding counties participated in this year’s North Central Ohio Walk to End ...